paroxetine

GPTKB entity

Statements (63)
Predicate Object
gptkbp:instanceOf antidepressant
selective serotonin reuptake inhibitor
gptkbp:approvedBy 1992
gptkbp:ATCCode N06AB05
gptkbp:brand gptkb:Paxil
gptkb:Seroxat
gptkbp:CASNumber 61869-08-7
gptkbp:chemicalClass gptkb:phenylpiperidine
gptkbp:contraindication concurrent use with MAO inhibitors
gptkbp:developedBy GlaxoSmithKline
gptkbp:drugInteraction gptkb:beer
gptkb:tricyclic_antidepressants
gptkb:warfarin
gptkb:MAO_inhibitors
gptkb:NSAIDs
lithium
antipsychotics
anticonvulsants
other SSRIs
gptkbp:eliminationHalfLife 21 hours
gptkbp:excretion urine
feces
gptkbp:genericAvailable yes
gptkbp:hasMolecularFormula C19H20FNO3
https://www.w3.org/2000/01/rdf-schema#label paroxetine
gptkbp:KEGGID D02366
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits reuptake of serotonin
gptkbp:MedlinePlusID a698032
gptkbp:metabolism liver
gptkbp:overdoseSymptoms gptkb:arrhythmia
nausea
vomiting
tremor
seizures
drowsiness
gptkbp:pregnancyCategory D (US)
gptkbp:pregnancyRisk may cause birth defects
gptkbp:PubChem_CID gptkb:CHEMBL418
43815
DB00715
gptkbp:riskFactor gptkb:serotonin_syndrome
increased suicidal thoughts in young people
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
weight gain
sweating
insomnia
drowsiness
dry mouth
sexual dysfunction
withdrawal symptoms
gptkbp:UNII 41VRH5220H
gptkbp:usedFor gptkb:generalized_anxiety_disorder
gptkb:obsessive-compulsive_disorder
gptkb:panic_disorder
gptkb:post-traumatic_stress_disorder
gptkb:social_anxiety_disorder
gptkb:major_depressive_disorder
premenstrual dysphoric disorder
gptkbp:bfsParent gptkb:CYP2D6
gptkb:CYP3A4
gptkbp:bfsLayer 5